These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35982541)

  • 1. Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV.
    Mastrorosa I; Pinnetti C; Brita AC; Mondi A; Lorenzini P; Del Duca G; Vergori A; Mazzotta V; Gagliardini R; Camici M; De Zottis F; Fusto M; Plazzi MM; Grilli E; Bellagamba R; Cicalini S; Antinori A
    Clin Infect Dis; 2023 Feb; 76(3):e629-e637. PubMed ID: 35982541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
    Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
    Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
    Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
    Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cognitive reserve in mediating HIV-associated neurocognitive disorders in older adults living with-treated HIV in Mbeya, Tanzania: A cross-sectional observational study.
    M S; E K; N TR; E C; K S; Kaminyoge MS; B M; R W; G L; W K G; S-M P; B M
    Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6042. PubMed ID: 38141048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
    Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors.
    Richter E; Bornemann L; Korencak M; Alter G; Schuster M; Esser S; Boesecke C; Rockstroh J; Gunzer M; Streeck H
    J Virol; 2022 Mar; 96(5):e0173021. PubMed ID: 35019724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis.
    Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y
    Neurology; 2020 Nov; 95(19):e2610-e2621. PubMed ID: 32887786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania.
    Flack KA; Rainey ES; Urasa SJ; Koipapi S; Kalaria RN; Howlett WP; Mukaetova-Ladinska EB; Dekker MCJ; Gray WK; Walker RW; Dotchin CL; Mtwaile H; Lewis TCD; Stone LG; McNally RJQ; Makupa PC; Paddick SM
    Viruses; 2024 May; 16(6):. PubMed ID: 38932112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of obesity among people with HIV.
    Talathi R; Anekwe CV; Toribio M
    Curr Opin HIV AIDS; 2024 Jan; 19(1):1-5. PubMed ID: 37916907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
    Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
    AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime antiretroviral exposure and neurocognitive impairment in HIV.
    Amusan P; Power C; Gill MJ; Gomez D; Johnson E; Rubin LH; Fujiwara E
    J Neurovirol; 2020 Oct; 26(5):743-753. PubMed ID: 32720232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.
    Nichols SL; Bethel J; Garvie PA; Patton DE; Thornton S; Kapogiannis BG; Ren W; Major-Wilson H; Puga A; Woods SP
    J Adolesc Health; 2013 Dec; 53(6):763-71. PubMed ID: 23972941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.